Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€66.20
08.03.23
-
08.04.23
-5.63%
20.03.23

Future proof or reliable business model
fenjal 
08.03.23 50%
buy
Novocure Ltd

Start price
Target price
Perf. (%)
€64.20
16.03.22
€68.00
16.03.23
-6.99%
17.03.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
16.03.22 70%
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€36.83
03.05.22
€30.00
03.05.23
-38.60%
11.03.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
geldnutzer 
03.05.22 60%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.86
12.07.22
€2.10
12.07.23
-54.35%
11.03.23

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
12.07.22 60%
buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€2.02
23.01.23
-
23.01.24
-28.00%
03.03.23

Risky Investment
Global_Player 
23.01.23 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.14
16.10.22
-
16.10.23
-3.57%
18.02.23

Risky Investment
quelbe60 
16.10.22 50%
sell
Novocure Ltd

Start price
Target price
Perf. (%)
€68.89
02.01.23
€30.00
31.12.25
71.43%
05.01.23

Could be very worthwhile Investment >20% year
BiotechBee 
02.01.23 70%
buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€136.00
28.12.21
€142.00
28.12.22
-70.42%
29.12.22

Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
tbackenh 
28.12.21 60%
buy
Opko Health Inc.

Start price
Target price
Perf. (%)
€4.65
28.12.21
-
28.12.22
-75.54%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Maxi_Scalibusa 
28.12.21 0%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.99
27.12.21
€42.00
27.12.22
-5.05%
28.12.22

Could be worthwhile Investment >10% per year
melinda 
27.12.21 50%
buy
Neogen Corp.

Start price
Target price
Perf. (%)
€35.40
14.12.21
€38.00
14.12.22
-59.89%
15.12.22

Could be worthwhile Investment >10% per year
melinda 
14.12.21 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.20
07.12.22
-
07.12.23
-16.53%
10.12.22

Risky Investment
Vassago1 
07.12.22 50%
buy
Chemed Corp.

Start price
Target price
Perf. (%)
€426.00
07.12.21
€445.00
07.12.22
14.08%
08.12.22

Could be worthwhile Investment >10% per year
melinda 
07.12.21 50%
buy
Syneos Health, Inc.

Start price
Target price
Perf. (%)
€26.12
04.11.22
-
04.11.23
23.91%
10.11.22

Risky Investment
Wolf_of_WS 
04.11.22 50%
sell
Invitae Corp

Start price
Target price
Perf. (%)
€23.02
01.11.21
-
01.11.22
-87.22%
02.11.22

Probably not worthwhile Investment
Lokrim 
01.11.21 20%
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
Wolf_of_WS 
28.10.22 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.47
27.09.22
-
27.09.23
-13.02%
15.10.22

Risky Investment
quelbe60 
27.09.22 50%
buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€158.00
28.09.21
-
28.09.22
0.63%
28.09.22

Saftman 
28.09.21 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.76
02.09.22
-
02.09.23
-10.51%
27.09.22

Could be very worthwhile Investment >20% year
Wolf_of_WS 
02.09.22 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€76.50
21.08.22
€230.00
21.08.23
6.54%
04.09.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Ruckelsbuckel 
21.08.22 50%
sell
Invitae Corp

Start price
Target price
Perf. (%)
€3.50
21.08.22
€1.00
21.08.23
-21.28%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
21.08.22 50%
sell
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
21.08.22
€87.00
21.08.23
-3.44%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
21.08.22 60%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€3.32
26.08.22
-
26.08.23
-17.03%
03.09.22

Could be very worthwhile Investment >20% year
Global_Player 
26.08.22 50%
buy
Molina Healthcare

Start price
Target price
Perf. (%)
€247.40
20.10.21
€280.00
31.12.23
39.05%
01.09.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
20.10.21 70%
buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€91.50
10.08.21
-
10.08.22
-42.25%
10.08.22

Saftman 
10.08.21 50%